Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-Analysis.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 17 1 2020
medline: 14 8 2020
entrez: 17 1 2020
Statut: ppublish

Résumé

Postoperative atrial fibrillation (POAF) is a frequent occurrence after noncardiac surgery. It remains unclear whether POAF is associated with an increased risk of major adverse events. We aimed to elucidate the risk of stroke, myocardial infarction, and death associated with POAF following noncardiac surgery by a meta-analysis of randomized controlled studies and observational studies. We searched electronic databases from inception up to August 1, 2019 for all studies that reported stroke or myocardial infarction in adult patients who developed POAF following noncardiac surgery. We used random-effects models to summarize the studies. The final analyses included 28 studies enrolling 2 612 816 patients. At 1-month (10 studies), POAF was associated with an ≈3-fold increase in the risk of stroke (weighted mean 2.1% versus 0.7%; odds ratio [OR], 2.82 [95% CI, 2.15-3.70]; POAF was associated with markedly higher risk of stroke, myocardial infarction, and all-cause mortality following noncardiac surgery. Future studies are needed to evaluate the impact of optimal cardiovascular pharmacotherapies to prevent POAF and to decrease the risk of major adverse events in these high-risk patients.

Sections du résumé

BACKGROUND
Postoperative atrial fibrillation (POAF) is a frequent occurrence after noncardiac surgery. It remains unclear whether POAF is associated with an increased risk of major adverse events. We aimed to elucidate the risk of stroke, myocardial infarction, and death associated with POAF following noncardiac surgery by a meta-analysis of randomized controlled studies and observational studies.
METHODS
We searched electronic databases from inception up to August 1, 2019 for all studies that reported stroke or myocardial infarction in adult patients who developed POAF following noncardiac surgery. We used random-effects models to summarize the studies.
RESULTS
The final analyses included 28 studies enrolling 2 612 816 patients. At 1-month (10 studies), POAF was associated with an ≈3-fold increase in the risk of stroke (weighted mean 2.1% versus 0.7%; odds ratio [OR], 2.82 [95% CI, 2.15-3.70];
CONCLUSIONS
POAF was associated with markedly higher risk of stroke, myocardial infarction, and all-cause mortality following noncardiac surgery. Future studies are needed to evaluate the impact of optimal cardiovascular pharmacotherapies to prevent POAF and to decrease the risk of major adverse events in these high-risk patients.

Identifiants

pubmed: 31944855
doi: 10.1161/CIRCEP.119.007437
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e007437

Auteurs

Ahmed AlTurki (A)

Division of Cardiology (A.A., V.E., T.H.), McGill University Health Center, Montreal, QC, Canada.

Mariam Marafi (M)

Department of Neurology and Neurosurgery, Montreal Neurological Institute, QC, Canada (M.M., L.V.).

Riccardo Proietti (R)

Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy (R.P.).

Daniela Cardinale (D)

Cardioncology Unit, European Institute of Oncology, I.R.C.C.S, Milan, Italy (D.C.).

Robert Blackwell (R)

Department of Urology, Loyola University Health Center, Chicago, IL (R.B.).

Paul Dorian (P)

Division of Cardiology, St Michael's Hospital, University of Toronto, ON, Canada (P.D.).

Amal Bessissow (A)

Division of General Internal Medicine (A.B.), McGill University Health Center, Montreal, QC, Canada.

Lucy Vieira (L)

Department of Neurology and Neurosurgery, Montreal Neurological Institute, QC, Canada (M.M., L.V.).

Isabelle Greiss (I)

Division of Cardiology, Univerity of Montreal Health Centre, QC, Canada (I.G.).

Vidal Essebag (V)

Division of Cardiology (A.A., V.E., T.H.), McGill University Health Center, Montreal, QC, Canada.

Jeff S Healey (JS)

Population Health Research Institute, McMaster University, Hamilton, ON, Canada (J.S.H.).

Thao Huynh (T)

Division of Cardiology (A.A., V.E., T.H.), McGill University Health Center, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH